Cargando…
Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124
Derepression of wild-type p53 by suppressing its negative inhibitor iASPP (Inhibitor of apoptosis-stimulating protein of p53) represents a potential therapeutic option for cervical cancer (CC). Here, we reported a novel functional significance of iASPP upregulation in cervical tumorigenesis: iASPP a...
Autores principales: | Dong, Peixin, Xiong, Ying, Watari, Hidemichi, Hanley, Sharon JB, Konno, Yosuke, Ihira, Kei, Suzuki, Fumihiko, Yamada, Takahiro, Kudo, Masataka, Yue, Junming, Sakuragi, Noriaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073231/ https://www.ncbi.nlm.nih.gov/pubmed/27765948 http://dx.doi.org/10.1038/srep35480 |
Ejemplares similares
-
Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors
por: Dong, Peixin, et al.
Publicado: (2015) -
Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression
por: Dong, Peixin, et al.
Publicado: (2016) -
MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
por: Dong, Peixin, et al.
Publicado: (2016) -
EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis
por: Ihira, Kei, et al.
Publicado: (2017) -
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
por: Konno, Yosuke, et al.
Publicado: (2014)